The Whole-Brain "Global" Signal from Resting State FMRI As a Potential Biomarker of Quantitative State Changes in Glucose Metabolism
Overview
Affiliations
The evolution of functional magnetic resonance imaging to resting state (R-fMRI) allows measurement of changes in brain networks attributed to state changes, such as in neuropsychiatric diseases versus healthy controls. Since these networks are observed by comparing normalized R-fMRI signals, it is difficult to determine the metabolic basis of such group differences. To investigate the metabolic basis of R-fMRI network differences within a normal range, eyes open versus eyes closed in healthy human subjects was used. R-fMRI was recorded simultaneously with fluoro-deoxyglucose positron emission tomography (FDG-PET). Higher baseline FDG was observed in the eyes open state. Variance-based metrics calculated from R-fMRI did not match the baseline shift in FDG. Functional connectivity density (FCD)-based metrics showed a shift similar to the baseline shift of FDG, however, this was lost if R-fMRI "nuisance signals" were regressed before FCD calculation. Average correlation with the mean R-fMRI signal across the whole brain, generally regarded as a "nuisance signal," also showed a shift similar to the baseline of FDG. Thus, despite lacking a baseline itself, changes in whole-brain correlation may reflect changes in baseline brain metabolism. Conversely, variance-based metrics may remain similar between states due to inherent region-to-region differences overwhelming the differences between normal physiological states. As most previous studies have excluded the spatial means of R-fMRI metrics from their analysis, this work presents the first evidence of a potential R-fMRI biomarker for baseline shifts in quantifiable metabolism between brain states.
Thompson G Alzheimers Dement. 2025; 21(2):e70033.
PMID: 39989452 PMC: 11848582. DOI: 10.1002/alz.70033.
Differential energetic profile of signal processing in central vestibular neurons.
Kunz L, Straka H Front Neurol. 2024; 15:1469926.
PMID: 39655161 PMC: 11626471. DOI: 10.3389/fneur.2024.1469926.
Yatomi T, Tomasi D, Tani H, Nakajima S, Tsugawa S, Nagai N Front Neural Circuits. 2024; 18:1497897.
PMID: 39568980 PMC: 11576226. DOI: 10.3389/fncir.2024.1497897.
Impaired brain glucose metabolism in glucagon-like peptide-1 receptor knockout mice.
Li H, Fang Y, Wang D, Shi B, Thompson G Nutr Diabetes. 2024; 14(1):86.
PMID: 39389952 PMC: 11466955. DOI: 10.1038/s41387-024-00343-w.
Pan J, Chen G, Shan P, Chen C, Jiang D, Wang L Psychiatry Clin Psychopharmacol. 2024; 31(3):286-291.
PMID: 38765947 PMC: 11079708. DOI: 10.5152/pcp.2021.20011.